• Home
  • Agric
  • Sci & Tech
  • Health
  • Environment
  • Hausa News
  • More
    • Business/Banking & Finance
    • Politics/Elections
    • Entertainments & Sports
    • International
    • Investigation
    • Law & Human Rights
    • Africa
    • ACCOUNTABILITY/CORRUPTION
    • Hassan Gimba
    • Column
    • Prof. Jibrin Ibrahim
    • Prof. M.K. Othman
    • Defense/Security
    • Education
    • Energy/Electricity
    • Entertainment/Arts & Sports
    • Society and Lifestyle
    • Food & Agriculture
    • Health & Healthy Living
    • International News
    • Interviews
    • Investigation/Fact-Check
    • Judiciary/Legislature/Law & Human Rights
    • Oil & Gas/Mineral Resources
    • Press Freedom/Media/PR/Journalism
    • General News
    • Presidency
  • About Us
    • Contact Us
    • Board Of Advisory
    • Privacy Policy
    • Ethics Policy
    • Teamwork And Collaboration Policy
    • Fact-Checking Policy
    • Advertising
  • Media OutReach Newswire
    • Wire News
  • The Stories
Facebook Twitter Instagram
Trending
  • CBN, IFSB meet to deepen Islamic Finance Cooperation at IMF/World Bank meetings
  • Cardoso advocates stronger capacity development for Africa at IMF/World Bank dialogue
  • Dangote plans refinery IPO in 2026
  • Wike targets 80% budget implementation
  • Zoho urges digital adoption for women
  • FRSC warns against attacks on personnel
  • Foundation deploys health officers in Abia
  • Ogun police seek NDLEA collaboration
Facebook Twitter Instagram YouTube
AsheNewsAsheNews
  • Home
  • Agric

    Stakeholders push investment in Nigeria’s agribusiness

    April 16, 2026

    Nigeria faces 1m tonne palm oil deficit

    April 16, 2026

    WFP spends $5m on social protection in Nigeria

    April 16, 2026

    Dangote Sugar shareholders approve N500bn rights issue for expansion

    April 16, 2026

    Kenya pushes smart farming as Fahari Aviation, CropLife Kenya sign drone pact

    April 15, 2026
  • Sci & Tech

    Zoho urges digital adoption for women

    April 17, 2026

    MTN suspends xtratime over new FCCPC rules

    April 17, 2026

    NiRA launches DNS security for .ng domain

    April 16, 2026

    FG probes ‘sharp-sharp’ loan apps for data privacy breaches

    April 14, 2026

    SCB-Africa intensifies efforts to bridge science-policy gap in biodiversity conservation

    April 14, 2026
  • Health

    Foundation deploys health officers in Abia

    April 17, 2026

    UNILAG medicine faculty targets clinical innovation

    April 16, 2026

    Parasite free world unrealistic – FUTA professor

    April 16, 2026

    Niger first lady launches immunization campaign

    April 16, 2026

    Nigeria records rising lassa fever deaths

    April 15, 2026
  • Environment

    FG hands over 132 housing units to Kwara

    April 17, 2026

    SON hosts workshop on motor energy standards

    April 16, 2026

    Nigeria pushes for better water, sanitation

    April 15, 2026

    LAWMA launches green waste training

    April 15, 2026

    Flood: Nigeria’s 33 states at high risk in 2026 [FULL LIST]

    April 15, 2026
  • Hausa News

    Otti plans 250-room 5-star hotel in Umuahia

    April 11, 2026

    Anti-quackery task force seals 4 fake hospitals in Rivers

    August 29, 2025

    [BIDIYO] Yadda na lashe gasa ta duniya a fannin Ingilishi – Rukayya ‘yar shekara 17

    August 6, 2025

    A Saka Baki, A Sasanta Saɓani Tsakanin ‘Yanjarida Da Liman, Daga Muhammad Sajo

    May 21, 2025

    Dan majalisa ya raba kayan miliyoyi a Funtuwa da Dandume

    March 18, 2025
  • More
    1. Business/Banking & Finance
    2. Politics/Elections
    3. Entertainments & Sports
    4. International
    5. Investigation
    6. Law & Human Rights
    7. Africa
    8. ACCOUNTABILITY/CORRUPTION
    9. Hassan Gimba
    10. Column
    11. Prof. Jibrin Ibrahim
    12. Prof. M.K. Othman
    13. Defense/Security
    14. Education
    15. Energy/Electricity
    16. Entertainment/Arts & Sports
    17. Society and Lifestyle
    18. Food & Agriculture
    19. Health & Healthy Living
    20. International News
    21. Interviews
    22. Investigation/Fact-Check
    23. Judiciary/Legislature/Law & Human Rights
    24. Oil & Gas/Mineral Resources
    25. Press Freedom/Media/PR/Journalism
    26. General News
    27. Presidency
    Featured
    Recent

    CBN, IFSB meet to deepen Islamic Finance Cooperation at IMF/World Bank meetings

    April 17, 2026

    Cardoso advocates stronger capacity development for Africa at IMF/World Bank dialogue

    April 17, 2026

    Dangote plans refinery IPO in 2026

    April 17, 2026
  • About Us
    1. Contact Us
    2. Board Of Advisory
    3. Privacy Policy
    4. Ethics Policy
    5. Teamwork And Collaboration Policy
    6. Fact-Checking Policy
    7. Advertising
    Featured
    Recent

    CBN, IFSB meet to deepen Islamic Finance Cooperation at IMF/World Bank meetings

    April 17, 2026

    Cardoso advocates stronger capacity development for Africa at IMF/World Bank dialogue

    April 17, 2026

    Dangote plans refinery IPO in 2026

    April 17, 2026
  • Media OutReach Newswire
    • Wire News
  • The Stories
AsheNewsAsheNews
Home»Health & Healthy Living»[EXPLAINER] Hepatitis: causes, symptoms, prevention
Health & Healthy Living

[EXPLAINER] Hepatitis: causes, symptoms, prevention

Abdallah el-KurebeBy Abdallah el-KurebeSeptember 1, 2024Updated:September 1, 2024No Comments4 Mins Read
Share
Facebook Twitter LinkedIn Pinterest Email

What is hepatitis?

According to the WHO, hepatitis is an inflammation of the liver that is caused by a variety of infectious viruses and non-infectious agents leading to a range of health problems, some of which can be fatal.

The virus has five main strains referred to as types A, B, C, D and E. While they all cause liver disease, they differ in important ways including modes of transmission, severity of the illness, geographical distribution and prevention methods.

In particular, types B and C lead to chronic disease in hundreds of millions of people and together are the most common cause of liver cirrhosis, liver cancer and viral hepatitis-related deaths. An estimated 354 million people worldwide live with B or C, and for most, testing and treatment remain beyond reach.

What are its symptoms?

The most common symptoms include:

  • Dark urine.
  • Stomach pain.
  • Yellow skin or eye whites, called jaundice.
  • Pale or clay-colored stool.
  • Low-grade fever.
  • Loss of appetite.
  • Fatigue.
  • Feeling sick to your stomach.
  • Aching joints.

Contact your healthcare provider as soon as possible if you have any or a combination of these symptoms.

What are its causes?

It is caused by a virus and can either be acute (lasting less than six months) or chronic (lasting more than six months). It can be spread from person to person. Some of its types can be spread through sexual contact.

How do we prevent it?

  1. Get vaccinated for Hepatitis A and B.
  2. Use clean and safe drinking water.
  3. Practice good hand hygiene, especially before eating.
  4. Avoid sharing needles or other drug paraphernalia.
  5. Use barrier protection (like condoms) during sexual activity
  6. Ensure safe blood transfusions and medical procedures
  7. Avoid sharing personal items like razors or toothbrushes
  8. Repost

How do we manage and treat it?

ALSO READ [EXPLAINER] What causes foamy urine?

There are no treatments to cure hepatitis A, aside from carefully monitoring liver function. If you know you have hepatitis A early enough, you might be able to stop the infection if you get a dose of the hepatitis A vaccine or something called hepatitis A immune globulin.

Hepatitis B, when chronic, can often be treated successfully. The most commonly used drugs to treat chronic hepatitis B are:

  • Entecavir (Baraclude®).
  • Telbivudine (Tyzeka®).
  • Tenofovir alafenamide (Vemlidy®).
  • Tenofovir disoproxil fumarate (Viread®).
  • Interferon alfa-2b (Intron A®).
  • Peginterferon alfa-2a (Pegasys®).

For hepatitis C, the following drugs are used:

  • Simeprevir (Olysio®).
  • Daclatasvir (Daklinza®).
  • Sofosbuvir (Solvadi®); sofusbuvir/velpatasvir (Epclusa®); sofusbuvir/velpatasvir/voxilaprevir (Vosevi®); ledipasvir/sofosbuvir (Harvoni®).
  • Ombitasvir/paritaprevir/ritonavir (Technivie®); ombitasvir/paritaprevir/ritonavir/dasabuvir (Viekira® Pak, Viekira® XR).
  • Elbasivir/grazoprevir (Zepatier®).
  • Glecaprevir/pibrentasvir (Mavyret®).

These new drugs are sometimes given with older drugs like ribavirin and peginterferon alfa-2a and peginterferon-2b. You might have to take these medicines for some time, even as long as six months.

If you have chronic hepatitis D, your doctor may prescribe drugs with interferons and might also add medicines for B. Hepatitis E treatments include peginterferon alfa-2a and ribavirin.

Is there a vaccine for it?

There are vaccines for hepatitis A and B that are available in the U.S. There is no vaccine for hepatitis C. Since you can only get hepatitis D if you have B, getting the vaccine against B should protect you against D. There is no FDA approved vaccine against hepatitis E, but vaccines against E exist overseas (for example, in China).

What is the outlook for hepatitis?

Hepatitis A and E usually only cause short-term (acute) infections that your body can overcome. The others (B, C and D) can also cause acute infections, but might also cause chronic (long-term) infections. The chronic forms are more dangerous. Hepatitis non-E is usually acute, but can become chronic.

Most people recover fully from the virus even though it might take several months for the liver to heal. To help improve your health and to help speed up your recovery:

  • Avoid alcohol.
  • Practice good nutrition.
  • If you feel sick, rest.
  • Talk to your healthcare provider about your medicines, even over-the-counter drugs or vitamins and supplements, to know which ones you should take and which to avoid until you are recovered.

With hepatitis, your healthcare provider will also be looking for long-term damage to the liver in the forms of cirrhosis or liver failure. You may be asked to take other types of tests, such as liver function tests, imaging tests or possibly a liver biopsy.

Viral hepatitis WHO
Share. Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Tumblr Email
Abdallah el-Kurebe
  • Website
  • Facebook
  • Twitter
  • LinkedIn

Related Posts

Foundation deploys health officers in Abia

April 17, 2026

UNILAG medicine faculty targets clinical innovation

April 16, 2026

Parasite free world unrealistic – FUTA professor

April 16, 2026

Leave A Reply Cancel Reply

CBN, IFSB meet to deepen Islamic Finance Cooperation at IMF/World Bank meetings

April 17, 2026

Cardoso advocates stronger capacity development for Africa at IMF/World Bank dialogue

April 17, 2026

Dangote plans refinery IPO in 2026

April 17, 2026

Wike targets 80% budget implementation

April 17, 2026
About Us
About Us

ASHENEWS (AsheNewsDaily.com), published by PenPlus Online Media Publishers, is an independent online newspaper. We report development news, especially on Agriculture, Science, Health and Environment as they affect the under-reported rural and urban poor.

We also conduct investigations, especially in the areas of ASHE, as well as other general interests, including corruption, human rights, illicit financial flows, and politics.

Contact Info:
  • 1st floor, Dogon Daji House, No. 5, Maiduguri Road, Sokoto
  • +234(0)7031140009
  • ashenewsdaily@gmail.com
Facebook Twitter Instagram Pinterest
© 2026 All Rights Reserved. ASHENEWS Daily Designed & Managed By DeedsTech

Type above and press Enter to search. Press Esc to cancel.